Skin Microbiome of Chinese Population Cohort Study

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Dec 31, 2025 → Dec 31, 2027
See other at-risk trials from Westlake University

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2027
    • Eligibility criteria expanded, about 3 words
  2. Minor Primary and study completion dates: Jul 7, 2025 to Dec 31, 2025
    • Eligibility criteria shortened, about 2 words
    v3
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 237
    • Start date changed from estimate of Apr 1, 2023 to May 8, 2023
    • Site details revised
    v2
  4. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes? Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.
Trial Details
NCT Number NCT05804851
Lead Sponsor Westlake University
Conditions
(from sponsor)
Skin Microbiome
Enrollment 237 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov